Tech Company Financing Transactions

Mission Bio Funding Round

Mission Bio, based in San Francisco, raised $70 million in investment from Novo Ventures, Agilent Technologies and Cota Capital.

Transaction Overview

Company Name
Mission Bio
Announced On
8/14/2020
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Series C
Investors

Novo Ventures (Lead Investor) (Robert Ghenchev)

Agilent Technologies (Darlene Solomon)

Cota Capital

Mayfield Fund (Ursheet Parikh)

Soleus Capital

Proceeds Purpose
The funds will scale its single-cell multi-omics technology, the Tapestri Platform, to expand the company's reach in more effective clinical trials for novel cancer treatments, as well as characterization for cell and gene therapy.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 104
San Francisco, CA 94080
USA
Phone
(415) 854-0058
Website
www.missionbio.com
Email Address
[email protected]
Overview
Mission Bio provides tools for the study of cellular heterogeneity in human health and life science research. Our approach relies on proprietary microfluidic droplet technology to deliver rapid and cost-effective solutions for molecular analysis of single cells.
Profile
Mission Bio LinkedIn Company Profile
Social Media
Mission Bio Company Twitter Account
Company News
Mission Bio News
Facebook
Mission Bio on Facebook
YouTube
Mission Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Charlie Silver
  Charlie Silver LinkedIn Profile  Charlie Silver Twitter Account  Charlie Silver News  Charlie Silver on Facebook
Chief Financial Officer
Marcel Roche
  Marcel Roche LinkedIn Profile  Marcel Roche Twitter Account  Marcel Roche News  Marcel Roche on Facebook
Chief Technical Officer
Nigel Beard
  Nigel Beard LinkedIn Profile  Nigel Beard Twitter Account  Nigel Beard News  Nigel Beard on Facebook
Vice President
Anup Parikh
  Anup Parikh LinkedIn Profile  Anup Parikh Twitter Account  Anup Parikh News  Anup Parikh on Facebook
VP - Bus. Development
Darrin Crisitello
  Darrin Crisitello LinkedIn Profile  Darrin Crisitello Twitter Account  Darrin Crisitello News  Darrin Crisitello on Facebook
VP - Bus. Development
Harsha Kavuri
  Harsha Kavuri LinkedIn Profile  Harsha Kavuri Twitter Account  Harsha Kavuri News  Harsha Kavuri on Facebook
VP - Engineering
Adam Sciambi
  Adam Sciambi LinkedIn Profile  Adam Sciambi Twitter Account  Adam Sciambi News  Adam Sciambi on Facebook
VP - Human Resources
Sharon Hebrok
  Sharon Hebrok LinkedIn Profile  Sharon Hebrok Twitter Account  Sharon Hebrok News  Sharon Hebrok on Facebook
VP - Marketing
Hannah Viernes
  Hannah Viernes LinkedIn Profile  Hannah Viernes Twitter Account  Hannah Viernes News  Hannah Viernes on Facebook
VP - Product Management
Anjali Pradhan
  Anjali Pradhan LinkedIn Profile  Anjali Pradhan Twitter Account  Anjali Pradhan News  Anjali Pradhan on Facebook
VP - R & D
David Ruff
  David Ruff LinkedIn Profile  David Ruff Twitter Account  David Ruff News  David Ruff on Facebook
VP - Sales
George Kopitas
  George Kopitas LinkedIn Profile  George Kopitas Twitter Account  George Kopitas News  George Kopitas on Facebook

 

 

Browse more venture capital transactions:

Prev: 8/14/2020: Cecelia Health venture capital transaction
Next: 8/14/2020: Sol Cuisine venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.